Drug delivery to tumours using a novel 5-FU derivative encapsulated into lipid nanocapsules-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug delivery to tumours using a novel 5-FU derivative encapsulated into lipid nanocapsules

Published:2018-11-29 Issue:5-6 Volume:27 Page:634-645
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Lollo Giovanna¹²³^ORCID,Matha Kevin³⁴,Bocchiardo Martina³,Bejaud Jérôme³,Marigo Ilaria⁵,Virgone-Carlotta Angelique⁶,Dehoux Thomas⁶,Rivière Charlotte⁶,Rieu Jean-Paul⁶,Briançon Stephanie¹²,Perrier Thomas⁷,Meyer Olivier⁷,Benoit Jean-Pierre¹²³

Affiliation:

1. Laboratoire d’Automatique et de Génie des Procédés (LAGEP), Univ Lyon, Université Claude Bernard Lyon 1, Villeurbanne, France;

2. Institut des Sciences Pharmaceutiques et Biologiques, Lyon, France;

3. MINT, INSERM U1066, CNRS UMR 6021, Université d’Angers, Angers, France;

4. Pharmacy Department, Angers University Hospital, Angers, France;

5. Veneto Institute of Oncology IOV-IRCCS, Padova, Italy;

6. Institut Lumière Matière, Univ Lyon, Université Claude Bernard Lyon 1, CNRS, Villeurbanne, France;

7. Carlina Technologies, Angers, France

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2018.1547733

Reference33 articles.

1. 5-Fluorouracil: mechanisms of action and clinical strategies

2. 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunity

3. Therapeutic targeting of myeloid-derived suppressor cells

4. DPD functional tests in plasma, fresh saliva and dried saliva samples as predictors of 5-fluorouracil exposure and occurrence of drug-related severe toxicity

5. DPD-based adaptive dosing of 5-FU in patients with head and neck cancer: impact on treatment efficacy and toxicity

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-vitro evaluation against pancreatic cancer;European Journal of Pharmaceutical Sciences;2024-05

2. Recent Developments in Nanotechnology and Immunotherapy for the Diagnosis and Treatment of Pancreatic Cancer;Current Pharmaceutical Biotechnology;2024-02-23

3. Glucospanlastics: innovative antioxidant and anticancer ascorbyl-2-glucoside vesicles for striking topical performance of repurposed itraconazole;RSC Advances;2024

4. Engineering lauric acid-based nanodrug delivery systems for restoring chemosensitivity and improving biocompatibility of 5-FU and OxPt against Fn-associated colorectal tumor;Journal of Materials Chemistry B;2024

5. Development of Novel Pyrimidine Nucleosides as Potential Anticancer Agents: Synthesis, Characterization, and Invitro Evaluation against pancreatic cancer;2023-12-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3